About Us
Relationship with the National Bleeding Disorders Foundation
A Message to Donors
Investment Strategy
Investment Approach
Investment Criteria and Process
Venture Philanthropy
Ways to Give
Our Portfolio
Who We Are
Media
Contact
About Us
Relationship with the National Bleeding Disorders Foundation
A Message to Donors
Investment Strategy
Investment Approach
Investment Criteria and Process
Venture Philanthropy
Ways to Give
Our Portfolio
Who We Are
Media
Contact
Be Biopharma Announces First Hemophilia Patient Dosed with New Cell Therapy
Jul 30, 2025 |
Article
External Link:
https://www.bleeding.org/news/be-biopharma-announces-first-hemophilia-patient-dosed-with-new-cell-therapy
